Projects funded by the NCN
Targeting adenylate kinase 4 (AK4) as a new paradigm in the treatment of non-small cell lung cancer: discovery and evaluation of the first small-molecule inhibitors
2023/51/B/NZ7/03056
Keywords:
Adenylate kinase 4 non-small cell lung cancer tumor microenvironment compound libraries enzyme inhibition drug discovery lung diseases
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ3_1: Cell biology
- ST4_3: Molecular architecture and structure
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy
woj. kujawsko-pomorskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 8
Call: OPUS 26 - announced on 2023-09-18
Amount awarded: 1 564 317 PLN
Project start date (Y-m-d): 2024-07-24
Project end date (Y-m-d): 2027-07-23
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.